Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,378.0
16.9 (0.50%)

 

  • STI Straits Times Index
    3,378.0
    16.9 (0.50%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,658.2
    9.3 (0.56%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,765.4
    303.7 (1.07%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,924.2
    23.0 (0.79%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,467.0
    420.8 (2.00%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,456.5
    53.2 (0.83%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,094.4
    27.8 (1.35%)
    Index delayed 20 minutes
  • XAO XAO
    6,786.2
    50.8 (0.75%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 951.8M
  • Value: 1,059.6M
  • Rise: 198
  • Fall: 120
  • Unch: 520

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Libra0.052+0.025
QT Vascular0.006+0.002
Sino Grandness0.050+0.004
SunMoonFood^0.063+0.005
Koh Eco0.058+0.001
G Invacom^0.137+0.005
Genting Sing0.920-
Sen Yue0.038-
Golden Agri-Res0.300-
TEE Intl0.102+0.001

World Indices

World Indices
Name Last Change
Nasdaq 8,146.5 -60.8
HSI 28,765.4 +303.7
HSCEI 10,909.4 +124.9
Jakarta 6,456.5 +53.2
Nikkei 225 21,467.0 +420.8
SSE Comp 2,924.2 +23.0
Shanghai A 3,062.8 +24.1
Shanghai B 290.0 +1.3
ShenZhen A 1,631.7 +12.2
ShenZhen B 972.3 +3.6
Taiwan W 10,873.2 +73.9
PSE Comp 0.0
KOSPI 2,094.4 +27.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

LEE'S PHARM LEE'S PHARM
Quotes 15 Minutes Delayed. Updated at 19 Jul 2019 16:08
Last (HKD): 5.180 Change: - High: 5.220 Remarks: -
Change (%): - Low: 5.130
Open 5.190 Yesterday's Close 5.180
Buy Price 5.150 Sell Price 5.180
Buy Volume ('000) 5.5 Sell Volume ('000) 9.5
Cumulative Volume ('000) 147.5 Cumulative Value 763,955
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.70617 Trailing EPS (HKD) e 0.70617 NAV (HKD) b 3.7321
PE a 7.335 Trailing PE f 7.335 Price / NAV b 1.3880
Dividend (HKD) d 0.117944 Cash In Hand (HKD) g 0.3753 Issued & Paid-up Shares c 592,309,000
Dividend Yield (%) d 2.277 Price / Cash In Hand g 13.802 Treasury Shares h -
Beta - 75 Daysi 0.843 R-Squared - 75 Days(%)i 17.58 Market Cap (M) 3,068.161
Beta - 500 Daysi 0.981 R-Squared - 500 Days (%)i 11.30 Enterprise Value (M) 2,750.443
Piotroski F Score 4 Exchange Code 950 Par Value ( HKD ) 0.05000
52 Weeks Volatility (%) 36.64 6-Month VWAP 6.419 Free Float (%) 50.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 Apr 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference LEE'S PHARM HKEx 3,068.161 7.335 7.335 1.3880 2.277
Industry Biotechnology HKEx 49,664.696 13.215 13.813 5.6269 2.736
Local Peer AMGEN-T HKEx 609,936.000 9.271 9.631 7.1731 4.272
Local Peer SINO BIOPHARM HKEx 112,772.358 10.525 10.803 3.2534 0.816
Local Peer WUXI BIO HKEx 101,735.436 136.210 136.209 11.1604 -
Local Peer BEIGENE HKEx 58,192.327 - - 4.6079 -
Local Peer 3SBIO HKEx 34,416.432 22.751 22.751 3.5034 -
Local Peer GENSCRIPT BIO HKEx 34,034.889 204.675 204.683 9.0819 -
Local Peer HAOHAI BIOTEC HKEx 7,586.147 15.450 15.450 1.8420 -
Local Peer FRONTAGE HKEx 6,886.205 78.168 78.162 20.1528 -
Local Peer VIVA BIOTECH HKEx 6,799.727 63.402 63.399 23.7194 -
Local Peer ASCLETIS-B HKEx 6,320.692 - - 1.6172 -
Local Peer CKLIFE SCIENCES HKEx 4,132.760 15.716 15.714 0.9693 2.326
Local Peer ESSEX BIO-TECH HKEx 4,051.649 17.532 17.533 4.3616 -
Other Local Peers BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), REGENT PACIFIC (HKEx), EXTRAWELL PHAR (HKEx), BIOSINO BIO-TEC (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 108,806.483 12.962 13.474 10.0449 3.055
Global Peer GILEAD SCIENCES INC NASDAQ 82,702.262 15.161 14.036 3.7676 3.534
Global Peer CSL ASX 101,856.584 45.649 41.810 14.7785 1.014
Global Peer CELGENE CORP NASDAQ 63,614.452 15.723 13.407 7.7911 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 44,598.350 21.274 20.697 9.4422 -
Global Peer BIOGEN INC NASDAQ 44,841.634 10.121 9.609 3.2424 -
Global Peer ILLUMINA INC NASDAQ 43,100.400 52.180 50.647 10.8157 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,684.289 13.371 13.464 3.4606 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 27,087.830 349.072 65.052 2.7907 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 21,708.719 68.699 19.435 4.2359 0.873
Other Global Peers INCYTE CORPORATION (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), SEATTLE GENETICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ARRAY BIOPHARMA INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MODERNA INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), TILRAY INC (NASDAQ), FIBROGEN INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), LIGAND PHARMACEUTICAL INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), INSMED INC (NASDAQ), NATERA INC (NASDAQ), REGENXBIO INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ANAPTYSBIO INC (NASDAQ), VERACYTE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), OPKO HEALTH INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), INTREXON CORP (NASDAQ), EDITAS MEDICINE INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), CORTEXYME INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), RADIUS HEALTH INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), RETROPHIN INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ARVINAS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), POLYNOVO LIMITED (ASX), OMEROS CORP (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), VANDA PHARMACE INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PERSONALIS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD (ASX), SYNTHORX INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), GLYCOMIMETICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NEXT SCIENCE LTD (ASX), AURINIA PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TRANSLATE BIO INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), DERMIRA INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PROTHENA CORP PLC (NASDAQ), NEXTCURE INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), RESTORBIO INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MERUS B V (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), IMMUNOGEN INC (NASDAQ), AGENUS INC (NASDAQ), KADMON HLDGS INC (NYSE), ACHILLION PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), TELIX PHARMACEUTIC (ASX), SYNDAX PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), GERON CORP (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), ATHERSYS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), DPHARMA (Bursa), RECRO PHARMA INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), COMPUGEN (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MANNKIND CORPORATION (NASDAQ), CHIASMA INC (NASDAQ), AFFIMED N V (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), AXCELLA HEALTH INC (NASDAQ), CHIMERIX INC (NASDAQ), STANDARD DIVERSIFIED INC (NYSE American), MERSANA THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), AXOVANT GENE THERAPIES LTD (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), ARDELYX INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), ALDEYRA THERAPEUTICS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IMV INC (NASDAQ), PFENEX INC (NYSE American), TOCAGEN INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BIOTIME INC (NYSE American), SESEN BIO INC (NASDAQ), NANTKWEST INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), HEMISPHERX BIOPHARMA INC (NYSE American), ADURO BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), ARBUTUS BIOPHARMA CORP (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), SUNESIS PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), EQUILLIUM INC (NASDAQ), TREVENA INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), INFINITY PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), SAVARA INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), PORT (SET), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), INFLARX N V (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), VERMILLION INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), EDAP TMS S.A. SPON ADS EACH REPR 1 ORD SHARE (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), ORGENESIS INC (NASDAQ), CURIS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), OUTLOOK THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), IBIO INC (NYSE American), COHBAR INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ARAVIVE INC (NASDAQ), CEL-SCI CORP (NYSE American), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), AQUINOX PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD (ASX), OPIANT PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), PHYLOGICA LIMITED (ASX), ORTHOCELL LIMITED (ASX), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), IMUGENE LIMITED (ASX), SEELOS THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), EVOGENE LTD (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), ZELDA THERAPEUTICS LTD (ASX), CONTRAFECT CORP (NASDAQ), RHINOMED LIMITED (ASX), BIOTRON (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), SENESTECH INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MEMPHASYS LTD (ASX), ONCOSIL MEDICAL LIMITED (ASX), ORAGENICS INC (NYSE American), ISORAY INC (NYSE American), HEAT BIOLOGICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SOLIGENIX INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ADALTA LTD (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), BIOCEPT INC (NASDAQ), HISTOGENICS CORP (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), CAPRICOR THERAPEUTICS INC (NASDAQ), PATRYS LIMITED (ASX), PRECIPIO INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), VICAL INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), IMMURON LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), BIONOMICS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NANOVIRICIDES INC (NYSE American), OHR PHARMACEUTICAL INC (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NOVELION THERAPEUTICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), GENETIC TECHNOLOGIES (ASX), REGENEUS LTD (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CELLMID LIMITED (ASX), TROVAGENE INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), VAXART INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADR EA REPR 150 ORD(POST SPLIT) (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CONATUS PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), Suntar Eco-City^ (SGX), XTL BIOPHARMACEUTICALS LTD SPON ADR EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), ADVAXIS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), BENITEC BIOPHARMA LTD (ASX), NEURALSTEM INC (NASDAQ), BIOXYNE LIMITED (ASX), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), QT Vascular (SGX), ACTINOGEN MEDICAL LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), MGRC (Bursa), MEGASUN (Bursa), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), OPGEN INC (NASDAQ), CCP TECHNOLOGIES LTD (ASX), CYTORI THERAPEUTICS INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), NOVITA HEALTHCARE LTD (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), MEDIBIO LIMITED (ASX), BPH ENERGY LIMITED (ASX), GENERA BIOSYSTEMS LIMITED (ASX), SINOVAC BIOTECH (NASDAQ), ALCHEMIA LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.060
+1.17 %
10 Days --0.300
-5.47 %
20 Days --0.050
-0.96 %
Medium Term Return 3 Months 0.084-1.850
-25.12 %
6 Months 0.084-1.020
-15.10 %
1 Year 0.118-4.700
-46.38 %
Long Term Return 2 Years 0.222-1.140
-14.53 %
3 Years 0.334-1.100
-12.20 %
Annualised Return Annualised --
-4.24 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 5.010 - 10.300 Change From 1 Year Low +0.170 % Change From 1 Year Low (%) +3.39
Change From 1 Year High -5.120 % Change From 1 Year High (%) -49.71
2 Years Range 5.010 - 14.700 Change From 2 Years Low +0.170 % Change From 2 Years Low (%) +3.39
Change From 2 Years High -9.520 % Change From 2 Years High (%) -64.76
5 Years Range 5.010 - 15.400 Change From 5 Years Low +0.170 % Change From 5 Years Low (%) +3.39
Change From 5 Years High -10.220 % Change From 5 Years High (%) -66.36
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture and sale of pharmaceutical products. It operates through the Proprietary Products and Licensed-in Products segments. The Proprietary Products segment involves in manufacturing and selling self-development pharmaceutical products. The Licensed-in Products segment offers trading of licensed-in pharmaceutical products. The company was founded on December 17, 2001 and is headquartered in Hong Kong.

Historical Price Data

Date Open High Low Close Volume VWAP
19 Jul 2019 5.190 5.220 5.130 5.180 147,500 5.1794
18 Jul 2019 5.400 5.400 5.140 5.180 322,000 5.1929
17 Jul 2019 5.300 5.300 5.210 5.260 175,500 5.2524
16 Jul 2019 5.270 5.320 5.200 5.200 677,500 5.2392
15 Jul 2019 5.120 5.220 5.100 5.220 477,500 5.1244
12 Jul 2019 5.160 5.190 5.110 5.120 345,900 5.1522
11 Jul 2019 5.200 5.250 5.150 5.200 331,000 5.1910
10 Jul 2019 5.690 5.690 5.130 5.200 495,078 5.2239
09 Jul 2019 5.400 5.410 5.110 5.240 534,000 5.2522
08 Jul 2019 5.430 5.600 5.340 5.370 642,000 5.4533
05 Jul 2019 5.450 5.590 5.450 5.480 254,000 5.4957
04 Jul 2019 5.430 5.620 5.410 5.470 772,000 5.5028
03 Jul 2019 5.300 5.470 5.300 5.410 689,500 5.3906
02 Jul 2019 5.280 5.380 5.210 5.300 777,500 5.3086
28 Jun 2019 5.170 5.280 5.170 5.250 557,899 5.2015
27 Jun 2019 5.230 5.280 5.180 5.210 114,500 5.2038
26 Jun 2019 5.140 5.320 5.140 5.260 68,500 5.2509
25 Jun 2019 5.200 5.380 5.190 5.190 77,500 5.2132
24 Jun 2019 5.210 5.330 5.190 5.210 77,500 5.2559
21 Jun 2019 5.200 5.290 5.170 5.230 205,000 5.2027
20 Jun 2019 5.190 5.330 5.130 5.300 285,000 5.2640
19 Jun 2019 5.270 5.270 5.180 5.240 247,500 5.2187
Summary
Current 2 Weeks
(08 Jul 2019 to 19 Jul 2019)
5.430 5.690 5.100 5.180 4,147,978 -
Previous 2 Weeks
(21 Jun 2019 to 05 Jul 2019)
5.200 5.690 5.100 5.480 3,593,899 -
4 Weeks from
(23 May 2019 to 20 Jun 2019)
5.990 5.990 5.100 5.300 5,778,805 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.